JF
BCRX icon

Jump Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History

Jump Financial’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.7M Buy
569,956
+460,547
+421% +$4.16M 0.05% 465
2026
Q1 		$1.04M Sell
109,409
-801,521
-88% -$6.22M 0.01% 902
2025
Q4 		$7.11M Sell
910,930
-13,846
-1% -$100K 0.09% 286
2025
Q3 		$7.02M Sell
924,776
-422,336
-31% -$3.52M 0.08% 306
2025
Q2 		$12.1M Buy
1,347,112
+1,198,263
+805% +$11.2M 0.13% 200
2025
Q1 		$1.12M Sell
148,849
-114,489
-43% -$923K 0.01% 785
2024
Q4 		$1.98M Sell
263,338
-8,401
-3% -$63.8K 0.04% 515
2024
Q3 		$2.07M Buy
271,739
+71,539
+36% +$544K 0.04% 502
2024
Q2 		$1.24M Buy
+200,200
New +$1.1M 0.02% 723
2024
Q1 		– Sell
-128,771
Closed -$771K – 1900
2023
Q4 		$771K Sell
128,771
-276,142
-68% -$1.6M 0.02% 841
2023
Q3 		$2.87M Buy
404,913
+319,037
+372% +$2.29M 0.11% 251
2023
Q2 		$605K Sell
85,876
-227,665
-73% -$1.83M 0.02% 936
2023
Q1 		$2.61M Buy
+313,541
New +$3.02M 0.11% 299
2022
Q1 		– Sell
-33,300
Closed -$461K – 1552
2021
Q4 		$461K Buy
+33,300
New +$441K 0.03% 689
2021
Q2 		– Sell
-19,105
Closed -$194K – 1084
2021
Q1 		$194K Buy
+19,105
New +$197K 0.02% 766
2020
Q4 		– Sell
-191,283
Closed -$657K – 951
2020
Q3 		$657K Buy
+191,283
New +$820K 0.13% 244

Other funds holding BCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Jump Financial's BCRX Position: Q2 2026 in Review

Jump Financial increased its BioCryst Pharmaceuticals (BCRX) stake by 421% in Q2 2026, buying an estimated $4.16M and bringing the position to 569,956 shares worth $5.7M. The position accounts for 0.05% of the portfolio, ranked #465.

Jump Financial first reported a position in BCRX in Q3 2020 and has held it in 16 quarters since. The position peaked at $12.1M in Q2 2025. 318 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

  • Jump Financial held 569,956 shares of BioCryst Pharmaceuticals worth $5.7M as of Q2 2026.
  • Jump Financial bought 460,547 BioCryst Pharmaceuticals shares in Q2 2026, an estimated $4.16M.
  • BioCryst Pharmaceuticals made up 0.05% of Jump Financial's portfolio in Q2 2026, its #465 holding.
  • Jump Financial first reported a position in BioCryst Pharmaceuticals in Q3 2020 and has held it in 16 quarters since.
  • Jump Financial's BioCryst Pharmaceuticals position peaked at $12.1M in Q2 2025.
  • 318 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.